Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat. (Q39460266)
Jump to navigation
Jump to search
scientific article published on 10 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat. |
scientific article published on 10 October 2011 |
Statements
1 reference
Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat. (English)
1 reference
Bruno S Pessôa
1 reference
Elisa B M I Peixoto
1 reference
Alexandros Papadimitriou
1 reference
Jacqueline M Lopes de Faria
1 reference
José B Lopes de Faria
1 reference
10 October 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference